-
-
Call more information
660-596-2224 -
I thought this was interesting so wanted to share. By DAMIAN GARDE JULY 5, 2018 Biogen is declaring success with a once-failed treatment for Alzheimer’s disease, pointing to positive secondary results from a mid-stage study in hopes of saving a drug many in the field had written off entirely. The treatment, BAN2401, failed its primary goal […]
Read MoreAuthors: Filbin MR et al. Crit Care Med 2018 Jun 29 And not for the reasons you might think. Sepsis can be both deadly and difficult to recognize. It is not clear whether treatment delays, such as delayed antibiotic administration, reflect poor recognition, poor quality care, or something else. To examine whether absence of explicit infectious […]
Read MoreASA Monitor 7 2018, Vol.82, 40-42. Review of unusual patient care experiences is a cornerstone of medical education. Each month, the AQI-AIRS Steering Committee abstracts a patient history submitted to the Anesthesia Incident Reporting System (AIRS) and authors a discussion of the safety and human factors challenges involved. Real-life case histories often include multiple clinical decisions, […]
Read MoreAnticonvulsant medications like gabapentin and pregabalin don’t appear to improve low back pain, a meta-analysis in the Canadian Medical Association Journal finds. Researchers examined nine studies of nearly 900 patients with chronic low back pain or lumbar radicular pain. Patients received either anticonvulsants (gabapentinoids or topiramate) or placebo. Gabapentinoids had no effect on low back pain or […]
Read MoreAuthor: Carolyn Crist (Reuters Health) – Hospitals that allow family members of critically ill patients to attend doctors’ rounds in the intensive care unit (ICU) may improve healthcare quality by enhancing communication and satisfaction, a Canadian study suggests. Although family attendance could increase the time spent on rounds, it doesn’t affect the quality of rounds […]
Read More